, Tracking Stock Market Picks
Enter Symbol:
ImmunoCellular Therapeutics Ltd (IMUC) [hlAlert]

3 Months Gains
down 72.22 %

ImmunoCellular Therapeutics Ltd (IMUC) rated Buy with price target $5 by Global Hunter Securities

Posted on: Thursday,  Dec 1, 2011  9:25 AM ET by Global Hunter Securities

ImmunoCellular Therapeutics Ltd (OTCBB: IMUC)
rated Buy with price target $5 by Global Hunter Securities.

ImmunoCellular Therapeutics, Ltd. is a development stage company that is seeking to develop and commercialize therapeutics to fight cancer using the immune system. The Company?s product candidate portfolio includes peptide based cellular immunotherapies targeting cancer stem cells, cellular immunotherapies targeting cancer antigens and monoclonal antibodies to diagnose and treat different cancers. As of December 31, 2008, the products under development include ICT-121, ICT-107, ICT-109, ICT-037, ICT-69 and ICT-Diagnostic-SCLC. In February 2008, the Company acquired certain monoclonal antibody related technology owned by Molecular Discoveries LLC (Molecular Discoveries).

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/1/2011 9:25 AM Buy
1.44 5.00
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy